United States · Platforms & data · The Motley Fool

Supernus (SUPN) Q3 2026 Earnings Call Transcript

Published by The Motley Fool · United States 1 h ago

Qelbree prescriptions surged 18% as revenue hit $226.8 million ahead of Indivior merger.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

After Intel’s historic stock drop, analysts say there’s no reason to buy the dip

Ondas stock drops despite expanded FEMA counter-drone funding

Alamar Biosciences (NASDAQ:ALMR) Stock Price Down 12.7% on Insider Selling

Air Force One flyover for White House Halloween event causes flight delays

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

AI Transcends Borders And Small Founders Pay A Disproportionate Cost